ftInvstr
BAFNAPH · Healthcare ₹472.8 +2.0% Mkt Cap ₹1124 Cr
← Search another stock

BAFNAPH

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹472.8
+2.0% today · 30d +13.11%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for BAFNAPH. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹27 Cr
-23.22% YoY
NET PROFIT
₹0 Cr
-97.78% YoY
OPM
9.8%
-6.28pp YoY
EPS
₹0.03
PE 146.58
◇ Sector Position
PEERPEROCE %
BAFNAPH146.58—
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
58
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation STRETCHED 5
Growth MUTED 40
Profitability DECENT 55
Technicals NEUTRAL 58
Risk LOW 90
Key Stats
TTM PE
146.58
P/B
11.89
52W HIGH
₹479.95
OFF HIGH
-1.49%
DIV YIELD
0.0%
MKT CAP
₹1124 Cr
◉ Active Signals
MACDNeutral-2.6531
RSI(14)Bearish70.78
Near 52W HighBullish-1.49
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold BAFNAPH and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.